These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
225 related items for PubMed ID: 11347668
1. Control of a community-wide outbreak of hepatitis A by mass vaccination with inactivated hepatitis A vaccine. Zamir C, Rishpon S, Zamir D, Leventhal A, Rimon N, Ben-Porath E. Eur J Clin Microbiol Infect Dis; 2001 Mar; 20(3):185-7. PubMed ID: 11347668 [Abstract] [Full Text] [Related]
3. Vaccination against hepatitis A in children aged 12 to 24 months [corrected]. Abarca K, Ibañez I, Flores J, Vial PA, Safary A, Potín M. Arch Med Res; 2001 Mar; 32(5):468-72. PubMed ID: 11578765 [Abstract] [Full Text] [Related]
14. Use of hepatitis A vaccine in a community-wide outbreak of hepatitis A. Craig AS, Sockwell DC, Schaffner W, Moore WL, Skinner JT, Williams IT, Shaw FE, Shapiro CN, Bell BP. Clin Infect Dis; 1998 Sep; 27(3):531-5. PubMed ID: 9770153 [Abstract] [Full Text] [Related]
15. Immunization against hepatitis A during an outbreak in a Jewish Orthodox community--Quebec, 1997-1998. Deshaies D, Dion R, Valiquette L, Auger N. Can Commun Dis Rep; 1998 Sep 15; 24(18):145-51. PubMed ID: 9780447 [No Abstract] [Full Text] [Related]
16. Immunogenicity of inactivated hepatitis A vaccine in children. Lee SD, Lo KJ, Chan CY, Yu MY, Wang YJ, Safary A. Gastroenterology; 1993 Apr 15; 104(4):1129-32. PubMed ID: 8462802 [Abstract] [Full Text] [Related]
17. Comparison of immunogenicity between inactivated and live attenuated hepatitis A vaccines: a single-blind, randomized, parallel-group clinical trial among children in Xinjiang Uighur Autonomous Region, China. Liu XE, Wushouer F, Gou A, Kuerban M, Li X, Sun Y, Zhang J, Liu Y, Li J, Zhuang H. Hum Vaccin Immunother; 2013 Jul 15; 9(7):1460-5. PubMed ID: 23571173 [Abstract] [Full Text] [Related]
18. [Evaluation on the effect of immunization and safety of live attenuated and inactivated hepatitis A vaccine in China]. Li H, Zhang XS, An J. Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Jan 15; 34(1):24-7. PubMed ID: 23648244 [Abstract] [Full Text] [Related]
20. Immunogenicity and safety of three consecutive lots of a new preservative-free inactivated hepatitis A vaccine (Healive): a double-blind, randomized and controlled trial. Jiang WP, Chen JT, Wang X, Wang YL, Liu Y, Chen WY, Xu WG, Qiu YZ, Yin WD. Vaccine; 2008 Apr 24; 26(18):2297-301. PubMed ID: 18395305 [Abstract] [Full Text] [Related] Page: [Next] [New Search]